OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Meta-analysis of cardiovascular outcome trials assessing the impact of glucagon-like peptide-1 receptor agonists on major cardiac arrhythmias
Aristi Boulmpou, Dimitrios Patoulias, Christodoulos Papadopoulos, et al.
Acta Cardiologica (2022) Vol. 78, Iss. 5, pp. 519-524
Closed Access | Times Cited: 11
Aristi Boulmpou, Dimitrios Patoulias, Christodoulos Papadopoulos, et al.
Acta Cardiologica (2022) Vol. 78, Iss. 5, pp. 519-524
Closed Access | Times Cited: 11
Showing 11 citing articles:
Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial
João Sérgio Neves, Francisco Vasques‐Nóvoa, Marta Borges‐Canha, et al.
Diabetes Obesity and Metabolism (2022) Vol. 25, Iss. 1, pp. 189-197
Open Access | Times Cited: 39
João Sérgio Neves, Francisco Vasques‐Nóvoa, Marta Borges‐Canha, et al.
Diabetes Obesity and Metabolism (2022) Vol. 25, Iss. 1, pp. 189-197
Open Access | Times Cited: 39
Antidiabetic agents and risk of atrial fibrillation/flutter: A comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists
André Scheen
Diabetes & Metabolism (2022) Vol. 48, Iss. 6, pp. 101390-101390
Closed Access | Times Cited: 22
André Scheen
Diabetes & Metabolism (2022) Vol. 48, Iss. 6, pp. 101390-101390
Closed Access | Times Cited: 22
Effects of GLP-1 receptor agonists on arrhythmias and its subtypes in patients with type 2 diabetes: A systematic review and meta-analysis
Jinjing Wei, Ruxin Wang, Haowen Ye, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 19
Jinjing Wei, Ruxin Wang, Haowen Ye, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 19
Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss
Allison B. Reiss, Shelly Gulkarov, Raymond Lau, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 408-408
Open Access
Allison B. Reiss, Shelly Gulkarov, Raymond Lau, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 408-408
Open Access
Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: A comprehensive review ranging from sulphonylureas to SGLT2 inhibitors
André Scheen
Diabetes & Metabolism (2022) Vol. 48, Iss. 6, pp. 101405-101405
Closed Access | Times Cited: 16
André Scheen
Diabetes & Metabolism (2022) Vol. 48, Iss. 6, pp. 101405-101405
Closed Access | Times Cited: 16
Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study
Yunwen Xu, Thomas A. Boyle, Beini Lyu, et al.
Journal of General Internal Medicine (2024) Vol. 39, Iss. 7, pp. 1112-1121
Closed Access | Times Cited: 3
Yunwen Xu, Thomas A. Boyle, Beini Lyu, et al.
Journal of General Internal Medicine (2024) Vol. 39, Iss. 7, pp. 1112-1121
Closed Access | Times Cited: 3
Association of glucagon-like peptide-1 receptor agonists with cardiac arrhythmias in patients with type 2 diabetes or obesity: a systematic review and meta-analysis of randomized controlled trials
Sijin Wu, Wenzhao Lu, Zhongli Chen, et al.
Diabetology & Metabolic Syndrome (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Sijin Wu, Wenzhao Lu, Zhongli Chen, et al.
Diabetology & Metabolic Syndrome (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Focus on cardiometabolic risk factors
Patrizio Lancellotti
Acta Cardiologica (2023) Vol. 78, Iss. 5, pp. 515-518
Open Access | Times Cited: 7
Patrizio Lancellotti
Acta Cardiologica (2023) Vol. 78, Iss. 5, pp. 515-518
Open Access | Times Cited: 7
Semaglutide for the prevention of atrial fibrillation: A systematic review and meta-analysis
Hongda Zhang, Lei Ding, Ke Liu, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 6, pp. 103067-103067
Closed Access | Times Cited: 1
Hongda Zhang, Lei Ding, Ke Liu, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 6, pp. 103067-103067
Closed Access | Times Cited: 1
A meta-analysis evaluating indirectly GLP-1 receptor agonists and arrhythmias in patients with type 2 diabetes and myocardial infarction
Zhi‐Jie Liu, Ning Bian, Shaorong Wu, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 7
Zhi‐Jie Liu, Ning Bian, Shaorong Wu, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 7
Glucose-lowering agents and risk of cardiac arrhythmias
André Scheen
Acta Cardiologica (2022) Vol. 78, Iss. 3, pp. 377-378
Closed Access | Times Cited: 4
André Scheen
Acta Cardiologica (2022) Vol. 78, Iss. 3, pp. 377-378
Closed Access | Times Cited: 4
